Ian Davis

Compliance with follow-up for patients with stage 1 testicular germ cell tumour

King Tung Cheung, Anthony Dat, Peter Wong, Caroline Dowling, Ian D Davis, Shomik Sengupta

Journal article  |  2020  |  ANZ Journal of Surgery

BACKGROUND: This study aimed to evaluate the compliance and loss-to-follow-up (LTFU) rate in patients with stage 1 testicular germ..

A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation

Robert J Ellis, Sharon J Del Vecchio, Kevin MJ Gallagher, Danielle N Aliano, Neil Barber, Damien M Bolton, Etienne TS Chew, Jeff S Coombes, Michael D Coory, Ian D Davis, James F Donaldson, Ross S Francis, Graham G Giles, Glenda C Gobe, Carmel M Hawley, David W Johnson, Alexander Laird, Steve Leung, Manar Malki, David JT Marco, et al.

Journal article  |  2020  |  Journal of the American Society of Nephrology

BACKGROUND: Clinically significant CKD following surgery for kidney cancer is associated with increased morbidity and mortality, b..

DASL-HiCAP (ANZUP1801): The impact of darolutamide on standard therapy for localized very high-risk cancer of the prostate-A randomized phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high-risk, clinically localized prostate cancer

Tamim Niazi, Scott Williams, Ian D Davis, Martin R Stockler, Andrew James Martin, Wendy Hague, Karen Bracken, Margot Gorzeman, Felicia Roncolato, Sonia Yip, Lisa Horvath, Shomik Sengupta, Simon Hughes, Raymond S McDermott, James WF Catto, Neha Vapiwala, Wendy R Parulekar, Christopher Sweeney

Conference Proceedings  |  2020  |  JOURNAL OF CLINICAL ONCOLOGY

Adding mitomycin to Bacillus Calmette-Guerin as adjuvant intravesical therapy for high-risk, nonmuscle-invasive urothelial bladder cancer (BCGMM; ANZUP 1301)

Elizabeth Chien Hern Liow, Dickon Hayne, Martin R Stockler, Andrew James Martin, Shomik Sengupta, Paul Anderson, Kate Ford, Mark Frydenberg, Margot Gorzeman, Will Green, Jeremy Grummet, Cynthia Hawks, Laurence Eliot Miles Krieger, Joseph Ischia, Steve McCombie, Manish Patel, Ian D Davis

Conference Proceedings  |  2020  |  JOURNAL OF CLINICAL ONCOLOGY

The role of renal mass biopsy in the management of small renal masses - patterns of use and surgeon opinion

Melinda M Protani, Andre Joshi, Victoria White, David JT Marco, Rachel E Neale, Michael D Coory, Graham G Giles, Damien M Bolton, Ian D Davis, Simon Wood, Susan J Jordan

Journal article  |  2020  |  Journal of Clinical Urology

Aims: Renal mass biopsy (RMB) is advocated to improve management of small renal masses, however there is concern about its clinica..

Body size and dietary risk factors for aggressive prostate cancer: a case-control study

Mikaela Pal, Allison M Hodge, Nathan Papa, Robert J MacInnis, Julie K Bassett, Damien Bolton, Ian D Davis, Jeremy Millar, Dallas R English, John L Hopper, Gianluca Severi, Melissa C Southey, Roger L Milne, Graham G Giles

Journal article  |  2019  |  Cancer Causes & Control

PURPOSE: Diet and body size may affect the risk of aggressive prostate cancer (APC), but current evidence is inconclusive. METHODS..

The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer

Hayley S Whitford, Pawel Kalinowski, Adrian Schembri, Peter Grimison, Martin Stockler, Andrew Martino, Guy C Toners, Ian D Davis, Paul Maruff, Ian N Olver

Journal article  |  2019  |  Supportive Care in Cancer

PURPOSE: The causal link between chemotherapy and cognitive impairment is unclear. We studied testicular cancer patients' objectiv..

TheraP: a randomized phase 2 trial of Lu-177-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

Michael S Hofman, Louise Emmett, John Violet, Alison Y Zhang, Nicola J Lawrence, Martin Stockler, Roslyn J Francis, Amir Iravani, Scott Williams, Arun Azad, Andrew Martin, Margaret McJannett, Ian D Davis

Journal article  |  2019  |  BJU International

OBJECTIVE: To assess the activity and safety of cabazitaxel chemotherapy vs that of treatment with 177 Lu-PSMA-617, a novel radiol..

The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of F-18-Fluoromethylcholine or Ga-68-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy

Ur Metser, Sue Chua, Bao Ho, Shonit Punwani, Edward Johnston, Frederic Pouliot, Noam Tau, Asmaa Hawsawy, Reut Anconina, Glenn Bauman, Rodney J Hicks, Andrew Weickhardt, Ian D Davis, Greg Pond, AndrewM Scott, Nina Tunariu, Harbir Sidhu, Louise Emmett

Journal article  |  2019  |  Journal of Nuclear Medicine

Purpose: To assess whether the addition of data from multiparametric pelvic (mpMR) and whole body MR (wbMR) to the interpretation ..

Assessment of Simplified Methods for Quantification of F-18-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer

Gerbrand M Kramer, Maqsood Yaqub, Herbert A Vargas, Robert C Schuit, Albert D Windhorst, Alfonsus JM van den Eertwegh, Astrid AM van der Veldt, Andries M Bergman, Eva M Burnazi, Jason S Lewis, Sua Chua, Kevin D Staton, Brad J Beattie, John L Humm, Ian D Davis, Andrew J Weickhardt, Andrew M Scott, Michael J Morris, Otto S Hoekstra, Adriaan A Lammertsma

Journal article  |  2019  |  Journal of Nuclear Medicine

OBJECTIVES:18F-fluorodihydrotestosterone (18F-FDHT) PET/CT potentially provides a noninvasive method for assessment of androgen re..

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Ian D Davis, Andrew J Martin, Martin R Stockler, Stephen Begbie, Kim N Chi, Simon Chowdhury, Xanthi Coskinas, Mark Frydenberg, Wendy E Hague, Lisa G Horvath, Anthony M Joshua, Nicola J Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott A North, Francis Parnis, Wendy Parulekar, David W Pook, et al.

Journal article  |  2019  |  New England Journal of Medicine

Lytic Effects of Water on Bladder Cancer Cells-Implications for Continuous Bladder Irrigation After TURBT

Ruchira Nandurkar, Pavel Sluka, Mo Li, Hady Wardan, Ian Davis, Shomik Sengupta

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Whole Blood Androgen Receptor-Based Gene Signature as a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer

Edmond M Kwan, Heidi Fettke, Maria M Docanto, Sarah Q To, Patricia Bukczynska, Andrew Mant, David Pook, Nicole Ng, Lisa-Jane K Graham, Stefano Mangiola, Eva Segelov, Kate Mahon, Ian D Davis, Phillip Parente, Carmel Pezaro, Tilman Todenhoefer, Lisa G Horvath, Arun A Azad

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Prospective, Multisite, International Comparison of F-18-Fluoromethylcholine PET/CT, Multiparametric MRI, and Ga-68-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient Outcomes

Louise Emmett, Ur Metser, Glenn Bauman, Rodney J Hicks, Andrew Weickhardt, Ian D Davis, Shonit Punwani, Greg Pond, Sue Chua, Bao Ho, Edward Johnston, Frederic Pouliot, Andrew M Scott

Journal article  |  2019  |  Journal of Nuclear Medicine

Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma

Robert J Ellis, Victoria M White, Damien M Bolton, Michael D Coory, Ian D Davis, Ross S Francis, Graham G Giles, Glenda C Gobe, David JT Marco, Rachel E Neale, Simon T Wood, Susan J Jordan, Graham Giles, Victoria White, Michael Coory, Jeremy Millar, Damien Bolton, Ian Davis, Ingrid Winship, Ian Roos, et al.

Journal article  |  2019  |  Clinical Genitourinary Cancer

Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells

Pavel Sluka, Carmel Pezaro, Hady Wardan, Shomik Sengupta, Ian D Davis

Journal article  |  2019  |  BJU International

The contribution of multiparametric pelvic and whole body MR to the interpretation of F-18-fluoromethylcholine(FCH) or Ga-68-HBED-CC PSMA-11 (PSMA) PET/CT in the detection of pelvic recurrence or distant metastases in patients with biochemical failure following radical prostatectomy.

Ur Metser, Sue Chua, Bao Ho, Shonit Punwani, Edward Johnston, Frederic Pouliot, Noam Tau, Asmaa Hawsawy, Reut Anconina, Glenn Bauman, Rodney Hicks, Andrew Weickhardt, Ian Davis, Greg Pond, Andrew Scott, Louise Emmett

Conference Proceedings  |  2019  |  JOURNAL OF NUCLEAR MEDICINE

TheraP: A randomized phase II trial of [Lu-177]-PSMA-617 theranostic versus cabazitaxel in progressive metastatic castration-resistant prostate cancer

Michael Hofman, Louise Emmett, John A Violet, Nicola Jane Lawrence, Scott Williams, Martin R Stockler, Roslyn J Francis, Amir Iravani, Alison Yan Zhang, Andrew James Martin, Arun Azad, Sonia Yip, Ailsa Langford, Margaret Mary McJannett, Ian D Davis

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Whole blood FOLH1 mRNA expression and treatment response in metastatic castration-resistant prostate cancer (mCRPC).

Edmond Michael Kwan, Sarah Q To, Heidi C Fettke, Maria M Docanto, Patricia Bukczynska, Andrew Michael Mant, David William Pook, Nicole Ng, Lisa-Jane K Graham, Eva Segelov, Kate Mahon, Ian D Davis, Phillip Parente, Carmel Jo Pezaro, Lisa Horvath, Arun Azad

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New Horizons

Anis A Hamid, Michael J Morris, Ian D Davis

Journal article  |  2019  |  European Urology Focus

Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature.

Jennifer A Soon, Angelyn Anton, Javier Torres, Ruth Lawrence, Phillip Parente, Joseph McKendrick, Ian D Davis, Carmel Pezaro

Journal article  |  2019  |  Supportive Care in Cancer

PURPOSE: Testicular seminomas occur in young men and are highly curable. Toxicities following treatment for men with extensive sta..

Management of patients with advanced prostate cancer in the Asia Pacific region: "real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017

Edmund Chiong, Declan G Murphy, Hideyuki Akaza, Nicholas C Buchan, Byung Ha Chung, Ravindran Kanesvaran, Makarand Khochikar, Jason Letran, Bannakij Lojanapiwat, Chi-fai Ng, Teng Ong, Yeong-Shiau Pu, Marniza Saad, Kathryn Schubach, Levent Turkeri, Rainy Umbas, Le Chuyen Vu, Scott Williams, Ding-Wei Ye, Ian D Davis

Journal article  |  2019  |  BJU International

Tumor size and postoperative kidney function following radical nephrectomy

Robert J Ellis, Victoria M White, Damien M Bolton, Michael D Coory, Ian D Davis, Ross S Francis, Graham G Giles, Glenda C Gobe, Rachel E Neale, Simon T Wood, Susan J Jordan

Journal article  |  2019  |  Clinical Epidemiology

Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross-sectional population-based study

Victoria M White, David JT Marco, Damien Bolton, Nathan Papa, Rachel E Neale, Michael Coory, Ian D Davis, Simon Wood, Graham G Giles, Susan J Jordan

Journal article  |  2018  |  BJU International

Reproducibility and Repeatability of Semiquantitative F-18-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study

Hebert Alberto Vargas, Gem M Kramer, Andrew M Scott, Andrew Weickhardts, Andreas A Meier, Nicole Parada, Bradley J Beattie, John L Humm, Kevin D Staton, Pat B Zanzonico, Serge K Lyashchenko, Jason S Lewis, Maqsood Yaqub, Ramon E Sosa, Alfons J van den Eertwegh, Ian D Davis, Uwe Ackermann, Kunthi Pathmaraj, Robert C Schuit, Albert D Windhorst, et al.

Journal article  |  2018  |  Journal of Nuclear Medicine

Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examination

Sue M Evans, Declan G Murphy, Ian D Davis, Shomik Sengupta, Ehsan Zare Borzeshi, Fanny Sampurno, Jeremy L Millar

Journal article  |  2018  |  Asia-Pacific Journal of Clinical Oncology

Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours

Nicola J Lawrence, Howard Chan, Guy Toner, Martin R Stockler, Andrew Martin, Sonia Yip, Nicole Wong, Annie Yeung, Danish Mazhar, Farzana Pashankar, Lindsay Frazier, Ray McDermott, Roderick Walker, Hsiang Tan, Ian D Davis, Peter Grimison

Journal article  |  2018  |  BMC Cancer

What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators' Preferences in the SORCE Trial.

Nicola J Lawrence, Andrew Martin, Ian D Davis, Simon Troon, Shomik Sengupta, Elizabeth Hovey, Xanthi Coskinas, Richard Kaplan, Benjamin Smith, Alastair Ritchie, Angela Meade, Tim Eisen, Prunella Blinman, Martin R Stockler

Journal article  |  2018  |  Kidney Cancer

Background: Decisions about adjuvant therapy involve trade-offs between possible benefits and harms. Objective: We sought to deter..

Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria

Melanie A Evans, Jeremy L Millar, Arul Earnest, Mark Frydenberg, Ian D Davis, Declan G Murphy, Paul Aidan Kearns, Sue M Evans

Journal article  |  2018  |  Medical Journal of Australia

Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis

Thomas Ahn, Robert J Ellis, Victoria M White, Damien M Bolton, Michael D Coory, Ian D Davis, Ross S Francis, Graham G Giles, Glenda C Gobe, Carmel M Hawley, David W Johnson, David JT Marco, Megan McStea, Rachel E Neale, Elaine M Pascoe, Simon T Wood, Susan J Jordan

Journal article  |  2018  |  Journal of Surgical Oncology

Answering Questions and Questioning Answers: More Evidence To Guide Decision-making About Chemohormonal Therapy in Metastatic Prostate Cancer

Ian D Davis

Journal article  |  2018  |  European Urology

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial

Jun Guo, Jie Jin, Mototsugu Oya, Hirotsugu Uemura, Shunji Takahashi, Katsunori Tatsugami, Sun Young Rha, Jae-Lyun Lee, Jinsoo Chung, Ho Yeong Lim, Hsi Chin Wu, Yen Hwa Chang, Arun Azad, Ian D Davis, Marlene J Carrasco-Alfonso, Bhupinder Nanua, Jackie Han, Qasim Ahmad, Robert Motzer

Journal article  |  2018  |  Journal of Hematology & Oncology

A prospective, multinational comparison of multi-parametric and whole body magnetic resonance imaging (mp-MRI and WB-MRI) F-18 fluoro-methyl-choline (FCH) and Ga-68 HBED-CC-(PSMA) in high risk men being considered for salvage radiation treatment for biochemical failure post radical prostatectomy: Detection rates, management impact and treatment response.

Louise Emmett, Ur Metser, Glenn Bauman, Rodney Hicks, Frederic Pouliot, Ian Davis, Sue Chua, Andrew Weickhardt, Shonit Punwani, Bao Ho, Edward Johnston, Andrew Scott

Conference Proceedings  |  2018  |  JOURNAL OF NUCLEAR MEDICINE

P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poorrisk metastatic germ cell tumors (GCTs).

Namrata Nayar, Nicola Jane Lawrence, Martin R Stockler, Andrew James Martin, Sonia Yip, Nicole Wong, Annie Yeung, Michael Friedlander, Danish Mazhar, Farzana Pashankar, David I Quinn, Ray McDermott, Rick Walker, Mark Winstanley, Fritha J Hanning, Andrew James Weickhardt, Amanda Gwendolyn Stevanovic, Ian D Davis, Guy C Toner, Peter S Grimison

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for high risk, clinically localized prostate cancer: ENZARAD (ANZUP 1303).

Scott Williams, Ian D Davis, Christopher Sweeney, Martin R Stockler, Andrew James Martin, Wendy Hague, Xanthi Coskinas, Sonia Yip, Emily Tu, Nicola Jane Lawrence, Namrata Nayar, Ray McDermott, Paul Kelly, Olwyn Deignan, Simon Hughes, Valerie Fonteyne, Bertrand F Tombal, Paul L Nguyen

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Pembrolizumab and chemoradiotherapy for muscle invasive bladder cancer: The ANZUP 1502 PCR-MIB trial.

Andrew James Weickhardt, Farshad Foroudi, Shomik Sengupta, Laura Galletta, Alan Herschtal, Peter S Grimison, Nitya Patanjali, Siobhan Ng, Colin Tang, Robert Goodwin, Elizabeth J Hovey, Tom Jarvis, Colin Chen, Shahneen Kaur Sandhu, Keen Hun Tai, Nathan Lawrentschuk, Ian D Davis

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Association of androgen receptor (AR) copy number gain with ARV7 expression and response to chemotherapy.

Mahesh Y Iddawela, Carmel Jo Pezaro, Pavel Sluka, Jenna Kraska, Michelle Pereira, Sachin Subhashrao Joshi, Shafaet Jamil, Muhammad Adnan Khattak, Siobhan Ng, Ian D Davis, Mel Ziman, Gail Risbridger, Elin Gray

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

Silke Gillessen, Gerhardt Attard, Tomasz M Beer, Himisha Beltran, Alberto Bossi, Rob Bristow, Brett Carver, Daniel Castellano, Byung Ha Chung, Noel Clarke, Gedske Daugaard, Ian D Davis, Johann de Bono, Rodolfo Borges dos Reis, Charles G Drake, Ros Eeles, Eleni Efstathiou, Christopher P Evans, Stefano Fanti, Felix Feng, et al.

Journal article  |  2018  |  European Urology

Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study

Nathan P Papa, Robert J MacInnis, Dallas R English, Damien Bolton, Ian D Davis, Nathan Lawrentschuk, Jeremy L Millar, Gianluca Severi, John L Hopper, Graham G Giles

Journal article  |  2018  |  Cancer Causes & Control

Development of Indicators to Assess Quality of Care for Prostate Cancer

Nupur Nag, Jeremy Millar, Ian D Davis, Shaun Costello, James B Duthie, Stephen Mark, Warick Delprado, David Smith, David Pryor, David Galvin, Frank Sullivan, Aine C Murphy, David Roder, Hany Elsaleh, David Currow, Craig White, Marketa Skala, Kim L Moretti, Tony Walker, Paolo De Ieso, et al.

Journal article  |  2018  |  European Urology Focus

BACKGROUND: The development, monitoring, and reporting of indicator measures that describe standard of care provide the gold stand..

Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based study

Victoria White, David JT Marco, Damien Bolton, Ian Douglas Davis, Michael Jefford, David Hill, Henry Miles Prince, Jeremy L Millar, Ingrid M Winship, Michael Coory, Graham G Giles

Journal article  |  2017  |  BJU International

Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case-control study

NP Papa, RJ MacInnis, H Jayasekara, DR English, D Bolton, ID Davis, N Lawrentschuk, JL Millar, J Pedersen, G Severi, MC Southey, JL Hopper, GG Giles

Journal article  |  2017  |  Prostate Cancer and Prostatic Diseases

Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study

Nathan P Papa, Robert J MacInnis, Dallas R English, Damien Bolton, Ian D Davis, Nathan Lawrentschuk, Jeremy L Millar, John Pedersen, Gianluca Severi, Melissa C Southey, John L Hopper, Graham G Giles

Journal article  |  2017  |  Urologic Oncology: Seminars and Original Investigations

Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer

CJ Pezaro, A Omlin, K Mastris, G Attard, TM Beer, KN Chi, S Chowdhury, ID Davis, CG Drake, JS de Bono, E Efstathiou, G Gravis, CS Higano, M Hussain, N James, CJ Logothetis, A Morgans, C Parker, CJ Ryan, F Saad, et al.

Journal article  |  2017  |  Annals of Oncology

Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category

Ian D Davis, Wanling Xie, Carmel Pezaro, Frede Donskov, J Connor Wells, Neeraj Agarwal, Sandy Srinivas, Takeshi Yuasa, Benoit Beuselinck, Lori A Wood, D Scott Ernst, Ravindran Kanesvaran, Jennifer J Knox, Allan Pantuck, Sadia Saleem, Ajjai Alva, Brian I Rini, Jae-Lyun Lee, Toni K Choueiri, Daniel YC Heng

Journal article  |  2017  |  European Urology

Randomised phase III trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for clinically localised, high risk, or node-positive prostate cancer: ENZARAD (ANZUP 1303).

Scott Williams, Ian D Davis, Christopher Sweeney, Martin R Stockier, Andrew James Martin, Wendy Hague, Xanthi Coskinas, Sonia Yip, Emily Tu, Nicola Jane Lawrence, Ray McDermott, Paul J Kelly, Olwyn Deignan, Simon Hughes, Valerie Fonteyne, Bertrand F Tombal, Paul L Nguyen

Conference Proceedings  |  2017  |  Journal of Clinical Oncology

BCG plus Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned

Dickon Hayne, Martin Stockler, Steve P McCombie, Nicola Lawrence, Andrew Martin, Shomik Sengupta, Ian D Davis

Journal article  |  2017  |  BJU International

A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant.

Ian D Davis, Juliet Quirk, Leone Morris, Lauren Seddon, Tsin Yee Tai, Genevieve Whitty, Tina Cavicchiolo, Lisa Ebert, Heather Jackson, Judy Browning, Duncan MacGregor, Frederick Wittke, Gregor Winkels, Regina Alex, Lena Miloradovic, Eugene Maraskovsky, Weisan Chen, Jonathan Cebon

Journal article  |  2017  |  Immunotherapy

AIM: Pilot clinical trial of NY-ESO-1 (ESO) protein in ISCOMATRIX™ adjuvant pulsed onto peripheral blood dendritic cells (PBDC), t..

Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial

Suzanne K Chambers, Stefano Occhipinti, Elizabeth Foley, Samantha Clutton, Melissa Legg, Martin Berry, Martin R Stockler, Mark Frydenberg, Robert A Gardiner, Stephen J Lepore, Ian D Davis, David P Smith

Journal article  |  2017  |  Journal of Clinical Oncology

Challenges of data sharing: valuable but costly?

Ian D Davis

Journal article  |  2017  |  The Lancet Oncology

The role of mindfulness in distress and quality of life for men with advanced prostate cancer

Suzanne K Chambers, Elizabeth Foley, Samantha Clutton, Robert McDowall, Stefano Occhipinti, Martin Berry, Martin R Stockler, Stephen J Lepore, Mark Frydenberg, Robert A Gardiner, Ian D Davis, David P Smith

Journal article  |  2016  |  Quality of Life Research

Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma

D Day, Y Kanjanapan, E Kwan, D Yip, N Lawrentschuk, ID Davis, AA Azad, S Wong, M Rosenthal, P Gibbs, B Tran

Journal article  |  2016  |  Internal Medicine Journal

Fully automated synthesis of [F-18]fluorodihydrotestosterone([F-18]FDHT) using the FlexLab module

Uwe Ackermann, Jason S Lewis, Kenneth Young, Michael J Morris, Andrew Weickhardt, Ian D Davis, Andrew M Scott

Journal article  |  2016  |  Journal of Labelled Compounds and Radiopharmaceuticals

Quality of care achievements of the Prostate Cancer Outcomes Registry-Victoria

Fanny Sampurno, Arul Earnest, Patabendi B Kumari, Jeremy L Millar, Ian D Davis, Declan G Murphy, Mark Frydenberg, Paul A Kearns, Sue M Evans

Journal article  |  2016  |  MEDICAL JOURNAL OF AUSTRALIA

Quality of care achievements of the Prostate Cancer Outcomes Registry-Victoria

Fanny Sampurno, Arul Earnest, Patabendi B Kumari, Jeremy L Millar, Ian D Davis, Declan G Murphy, Mark Frydenberg, Paul A Kearns, Sue M Evans

Journal article  |  2016  |  Medical Journal of Australia

Author reply "First, do no harm': managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer

AJ Lomax, P Parente, C Gilfillan, PM Livingston, ID Davis, C Pezaro

Journal article  |  2016  |  Internal Medicine Journal

Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men With Heterosexual Men

Jane M Ussher, Janette Perz, Andrew Kellett, Suzanne Chambers, David Latini, Ian D Davis, Duncan Rose, Gary W Dowsett, Scott Williams

Journal article  |  2016  |  The Journal of Sexual Medicine

Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro

Craig Gedye, Tracy Cardwell, Nektaria Dimopoulos, Bee Shin Tan, Heather Jackson, Suzanne Svobodova, Matthew Anaka, Andreas Behren, Christopher Maher, Oliver Hofmann, Winston Hide, Otavia Caballero, Ian D Davis, Jonathan Cebon

Journal article  |  2016  |  Stem Cell Reviews and Reports

"First, do no harm': managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer

AJ Lomax, P Parente, C Gilfillan, PM Livingston, ID Davis, C Pezaro

Journal article  |  2016  |  Internal Medicine Journal

Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach

Alicia K Morgans, Annelotte CM van Bommel, Caleb Stowell, Janet L Abrahm, Ethan Basch, Justin E Bekelman, Donna L Berry, Alberto Bossi, Ian D Davis, Theo M de Reijke, Louis J Denis, Sue M Evans, Neil E Fleshner, Daniel J George, Jim Kiefert, Daniel W Lin, Andrew G Matthew, Ray McDermott, Heather Payne, Ian AG Roos, et al.

Journal article  |  2015  |  EUROPEAN UROLOGY

Patterns of care for metastatic renal cell carcinoma in Australia

Daphne Day, Yada Kanjanapan, Edmond Kwan, Desmond Yip, Nathan Lawrentschuk, Miles Andrews, Ian D Davis, Arun A Azad, Mark Rosenthal, Shirley Wong, Alice Johnstone, Peter Gibbs, Ben Tran

Journal article  |  2015  |  BJU International

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

S Gillessen, A Omlin, G Attard, JS de Bono, E Efstathiou, K Fizazi, S Halabi, PS Nelson, O Sartor, MR Smith, HR Soule, H Akaza, TM Beer, H Beltran, AM Chinnaiyan, G Daugaard, ID Davis, M De Santis, CG Drake, RA Eeles, et al.

Journal article  |  2015  |  Annals of Oncology

Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes

Renu Eapen, Mun Sem Liew, Ali Tafreshi, Nathan Papa, Nathan Lawrentschuk, Arun Azad, Ian D Davis, Damien Bolton, Shomik Sengupta

Journal article  |  2015  |  ANZ Journal of Surgery

Comparison of [C-11] choline Positron Emission Tomography With T2-and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions

Joe H Chang, Daryl Lim Joon, Ian D Davis, Sze Ting Lee, Chee-Yan Hiew, Stephen Esler, Sylvia J Gong, Morikatsu Wada, David Clouston, Richard O'Sullivan, Yin P Goh, Damien Bolton, Andrew M Scott, Vincent Khoo

Journal article  |  2015  |  International Journal of Radiation Oncology*Biology*Physics

Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management

Crescens Tiu, Carmel Pezaro, Ian D Davis, Mathis Grossmann, Phillip Parente

Journal article  |  2015  |  Asia-Pacific Journal of Clinical Oncology

BCG plus MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)

Dickon Hayne, Martin Stockler, Steve P McCombie, Venu Chalasani, Anne Long, Andrew Martin, Shomik Sengupta, Ian D Davis

Journal article  |  2015  |  BMC Cancer

Low-dose cyclophosphamide enhances antigen-specific CD4( ) T cell responses to NY-ESO-1/ISCOMATRIX (TM) vaccine in patients with advanced melanoma

Oliver Klein, Ian D Davis, Grant A McArthur, Li Chen, Andrew Haydon, Phillip Parente, Nektaria Dimopoulos, Heather Jackson, Kun Xiao, Eugene Maraskovsky, Wendie Hopkins, Rodica Stan, Weisan Chen, Jonathan Cebon

Journal article  |  2015  |  Cancer Immunology, Immunotherapy

IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma

C-F Xu, T Johnson, J Garcia-Donas, TK Choueiri, CN Sternberg, ID Davis, N Bing, KC Deen, Z Xue, L McCann, E Esteban, JC Whittaker, CF Spraggs, C Rodriguez-Antona, LN Pandite, RJ Motzer

Journal article  |  2015  |  British Journal of Cancer

Can neutrophil-to-lymphocyte ratio be used to identify patients with metastatic renal cell carcinoma who may gain greater benefit from cytoreductive nephrectomy?

Daphne Dai, Yada Kanjanapan, Edmond Michael Kwan, Desmond Yip, Nathan Lawrentschuk, Ian D Davis, Arun Azad, Mark Rosenthal, Shams Ul Arifeen, Mahmood Alam, Peter Gibbs, Ben Tran

Conference Proceedings  |  2015  |  Journal of Clinical Oncology

Bladder and other urothelium

Gillian M Duchesne, Shomik Sengupta, Ian D Davis

Book Chapter  |  2015

Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre - impact on clinical decision-making and implications for patient inclusion

Kenny Rao, Kiran Manya, Arun Azad, Nathan Lawrentschuk, Damien Bolton, Ian D Davis, Shomik Sengupta

Journal article  |  2014  |  BJU International

A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme

David K Lau, Miles C Andrews, Natalie Turner, Arun A Azad, Ian D Davis, Jonathan S Cebon

Journal article  |  2014  |  Melanoma Research

USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer

Mun Sem Liew, Arun Azad, Ali Tafreshi, Renu Eapen, Damien Bolton, Ian D Davis, Shomik Sengupta

Journal article  |  2013  |  BJU International

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors

Matthew Anaka, Christopher Hudson, Pu-Han Lo, Hongdo Do, Otavia L Caballero, Ian D Davis, Alexander Dobrovic, Jonathan Cebon, Andreas Behren

Journal article  |  2013  |  BMC Medical Genomics

Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer

Peter Grimison, Baerin Houghton, Mark Chatfield, Guy C Toner, Ian D Davis, Jarad Martin, Elizabeth Hovey, Martin R Stockler

Journal article  |  2013  |  BJU International

The Ludwig Institute for Cancer Research Melbourne Melanoma Cell Line Panel

Andreas Behren, Matthew Anaka, Pu-Han Lo, Laura J Vella, Ian D Davis, Jenny Catimel, Tracy Cardwell, Craig Gedye, Christopher Hudson, Rodica Stan, Jonathan Cebon

Journal article  |  2013  |  Pigment Cell & Melanoma Research

Patients' and their doctors' preferences for adjuvant sorafenib after resection of intermediate to high risk RCC: what makes it worthwhile?

S Sengupta, P Blinman, J Thompson, T France, A Martin, I Davis, M Stockler

Conference Proceedings  |  2013  |  BJU International

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

Cora N Sternberg, Robert E Hawkins, John Wagstaff, Pamela Salman, Jozef Mardiak, Carlos H Barrios, Juan J Zarba, Oleg A Gladkov, Eunsik Lee, Cezary Szczylik, Lauren McCann, Stephen D Rubin, Mei Chen, Ian D Davis

Journal article  |  2013  |  European Journal of Cancer

Are we over-diagnosing and over-treating prostate cancer?

S Sengupta, I Davis, D Lim Joon, D Bolton, J Millar

Conference Proceedings  |  2013  |  BJU International

The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer

Sue M Evans, Jeremy L Millar, Julie M Wood, Ian D Davis, Damien Bolton, Graham G Giles, Mark Frydenberg, Albert Frauman, Antony Costello, John J McNeil

Journal article  |  2013  |  BJU International

Flt3 ligand expands CD4 FoxP3 regulatory T cells in human subjects

Oliver Klein, Lisa M Ebert, Damien Zanker, Katherine Woods, Bee Shin Tan, Jitka Fucikova, Andreas Behren, Ian D Davis, Eugene Maraskovsky, Weisan Chen, Jonathan Cebon

Journal article  |  2013  |  European Journal of Immunology

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma

Lisa M Ebert, Sarah E MacRaild, Damien Zanker, Ian D Davis, Jonathan Cebon, Weisan Chen

Journal article  |  2012  |  PLoS One

Intensity Modulated Radiation Therapy Dose Painting for Localized Prostate Cancer Using C-11-choline Positron Emission Tomography Scans

Joe H Chang, Daryl Lim Joon, Sze Ting Lee, Sylvia J Gong, Nigel J Anderson, Andrew M Scott, Ian D Davis, David Clouston, Damien Bolton, Christopher S Hamilton, Vincent Khoo

Journal article  |  2012  |  International Journal of Radiation: Oncology - Biology - Physics

A novel method for detecting antigen-specific human regulatory T cells

Lisa M Ebert, Sarah E MacRaild, Ian D Davis, Jonathan Cebon, Weisan Chen

Journal article  |  2012  |  Journal of Immunological Methods

Pathological responses to gemcitabine/platinum-based neoadjuvant chemotherapy for muscle-invasive urothelial cancer

Mun Sem Liew, George Au-Yeung, Ian D Davis

Journal article  |  2012  |  Asia Pacific Journal of Clinical Oncology

Oncology Health Information Quality on the Internet: a Multilingual Evaluation

Nathan Lawrentschuk, Deborah Sasges, Robert Tasevski, Robert Abouassaly, Andrew M Scott, Ian D Davis

Journal article  |  2012  |  Annals of Surgical Oncology

Urothelial cancers: using biology to improve outcomes

Carmel Pezaro, Mun Sem Liew, Ian D Davis

Journal article  |  2012  |  Expert Review of Anticancer Therapy

Histopathological correlation of C-11-choline PET scans for target volume definition in radical prostate radiotherapy

Joe H Chang, Daryl Lim Joon, Sze Ting Lee, Sylvia J Gong, Andrew M Scott, Ian D Davis, David Clouston, Damien Bolton, Christopher S Hamilton, Vincent Khoo

Journal article  |  2011  |  Radiotherapy and Oncology

Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate

Suzanne Svobodova, Judy Browning, Duncan MacGregor, Gabriele Pollara, Richard A Scolyer, Rajmohan Murali, John F Thompson, Siddhartha Deb, Arun Azad, Ian D Davis, Jonathan S Cebon

Journal article  |  2011  |  European Journal of Cancer

Prostate cancer immunology - an update for urologists

N RAJARUBENDRA, N Lawrentschuk, DM Bolton, undefined Klotz, ID Davis

Journal article  |  2011  |  Journal of Urology

Potential of imaging biomarkers for characterization of renal masses

Nathan Lawrentschuk, Andrew M Scott, Ian D Davis

Journal article  |  2010  |  Expert Review of Anticancer Therapy

Functional imaging of renal cell carcinoma

Nathan Lawrentschuk, Ian D Davis, Damien M Bolton, Andrew M Scott

Journal article  |  2010  |  Nature Reviews Urology

Breast and prostate cancer: more similar than different

Gail P Risbridger, Ian D Davis, Stephen N Birrell, Wayne D Tilley

Journal article  |  2010  |  Nature Reviews Cancer

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Cora N Sternberg, Ian D Davis, Jozef Mardiak, Cezary Szczylik, Eunsik Lee, John Wagstaff, Carlos H Barrios, Pamela Salman, Oleg A Gladkov, Alexander Kavina, Juan J Zarba, Mei Chen, Lauren McCann, Lini Pandite, Debasish F Roychowdhury, Robert E Hawkins

Journal article  |  2010  |  Journal of Clinical Oncology

Cancer/testis antigens can be immunological targets in clonogenic CD133( ) melanoma cells

Craig Gedye, Juliet Quirk, Judy Browning, Suzanne Svobodova, Thomas John, Pavel Sluka, P Rod Dunbar, Denis Corbeil, Jonathan Cebon, Ian D Davis

Journal article  |  2009  |  Cancer Immunology, Immunotherapy

An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate Cancer

Carmel Pezaro, Mark A Rosenthal, Howard Gurney, Ian D Davis, Craig Underhill, Michael J Boyer, Dusan Kotasek, Benjamin Solomon, Guy C Toner

Journal article  |  2009  |  American Journal of Clinical Oncology - Cancer Clinical Trials

O-6-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib

AJ Watson, MR Middleton, G McGown, M Thorncroft, M Ranson, P Hersey, G McArthur, ID Davis, D Thomson, J Beith, A Haydon, R Kefford, P Lorigan, P Mortimer, A Sabharwal, O Hayward, GP Margison

Journal article  |  2009  |  British Journal of Cancer

Melan-A-specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4

Oliver Klein, Lisa M Ebert, Theo Nicholaou, Judy Browning, Sarah E Russell, Marina Zuber, Heather M Jackson, Nektaria Dimopoulos, Bee Shin Tan, Axel Hoos, Immanuel F Luescher, Ian D Davis, Weisan Chen, Jonathan Cebon

Journal article  |  2009  |  Clinical Cancer Research

Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial

Ian D Davis, Ben Brady, Richard F Kefford, Michael Millward, Jonathan Cebon, Birte K Skrumsager, Ulrik Mouritzen, Lasse Tengbjerg Hansen, Kresten Skak, Dorthe Lundsgaard, Klaus Stensgaard Frederiksen, Paul EG Kristjansen, Grant McArthur

Journal article  |  2009  |  Clinical Cancer Research

Regulatory T-Cell - Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma

Theo Nicholaou, Lisa M Ebert, Ian D Davis, Grant A McArthur, Heather Jackson, Nektaria Dimopoulos, Bee Tan, Eugene Maraskovsky, Lena Miloradovic, Wendie Hopkins, Linda Pan, Ralph Venhaus, Eric W Hoffman, Weisan Chen, Jonathan Cebon

Journal article  |  2009  |  Clinical Cancer Research

A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design

Lisa M Ebert, Yu Chih Liu, Craig S Clements, Neil C Robson, Heather M Jackson, Jessica L Markby, Nektaria Dimopoulos, Bee Shin Tan, Immanuel F Luescher, Ian D Davis, Jamie Rossjohn, Jonathan Cebon, Anthony W Purcell, Weisan Chen

Journal article  |  2009  |  Cancer Research

Therapeutic Efficacy of Lu-177-CHX-A ''-DTPA-hu3S193 Radioimmunotherapy in Prostate Cancer Is Enhanced by EGFR Inhibition or Docetaxel Chemotherapy

Marcus P Kelly, Sze Ting Lee, F-T Lee, Fiona E Smyth, Ian D Davis, Martin W Brechbiel, Andrew M Scott

Journal article  |  2009  |  The Prostate

Clinical Use of Therapies Targeting Tumor Vasculature and Stroma

Ian D Davis, Jayesh Desai

Journal article  |  2008  |  Current Cancer Drug Targets

IL-21 induces in vivo immune activation of NK cells and CD8( ) T cells in patients with metastatic melanoma and renal cell carcinoma

Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A Freeman, Steven D Hughes, Thomas L Holm, Birte K Skrumsager, Andreas Petri, Lasse T Hansen, Grant A McArthur, Ian D Davis, Kresten Skak

Journal article  |  2008  |  Cancer Immunology, Immunotherapy

Thyrotoxicosis during sunitinib treatment for renal cell carcinoma

Mathis Grossmann, Erosha Premaratne, Jayesh Desai, Ian D Davis

Journal article  |  2008  |  Clinical Endocrinology

Predicting clinical outcome through molecular profiling in stage III melanoma

Thomas John, Michael A Black, Tumi T Toro, Debbie Leader, Craig A Gedye, Ian D Davis, Parry J Guilford, Jonathan S Cebon

Journal article  |  2008  |  Clinical Cancer Research

ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer

Thomas John, Otavia L Caballero, Suzanne J Svobodova, Alan Kong, Ramon Chua, Judy Browning, Sheila Fortunato, Siddhartha Deb, Melinda Hsu, Craig A Gedye, Ian D Davis, Nasser Altorki, Andrew J Simpson, Yao-Tseng Chen, Marilyn Monk, Jonathan S Cebon

Journal article  |  2008  |  Clinical Cancer Research

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells

Lisa M Ebert, Bee Shin Tan, Judy Browning, Suzanne Svobodova, Sarah E Russell, Naomi Kirkpatrick, Craig Gedye, Denis Moss, Sweet Ping Ng, Duncan MacGregor, Ian D Davis, Jonathan Cebon, Weisan Chen

Journal article  |  2008  |  Cancer Research

Targeted therapies in the treatment of renal cell carcinoma.

Carmel Pezaro, Ian D Davis

Journal article  |  2008  |  Current Medicinal Chemistry

The management of renal cell carcinoma (RCC) has undergone rapid and radical evolution over the last few years. An improved unders..

Peripheral primitive neuroectodermal tumor arising from the seminal vesicle

Nathan Lawrentschuk, Sree Appu, Ian Chao, Yee Chan, John Rogerson, Ian D Davis

Journal article  |  2008  |  Urologia Internationalis

Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer

Ian D Davis, Guy Toner, Adam Broad, Louise M Campano, Mark Rosenthal

Journal article  |  2007  |  Asia-Pacific Journal of Clinical Oncology

A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.

Ian D Davis, Gregory A Wiseman, Fook-Thean Lee, Denise N Gansen, Wendie Hopkins, Anthony T Papenfuss, Zhanqi Liu, Timothy J Moynihan, Gary A Croghan, Alex A Adjei, Eric W Hoffman, James N Ingle, Lloyd J Old, Andrew M Scott

Journal article  |  2007  |  Cancer Immunity

The chimeric monoclonal antibody cG250 recognises the G250/CAIX/MN antigen found on 95% of clear cell renal cell carcinomas (RCCs)..

A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.

Ian D Davis, Zhanqi Liu, Wayne Saunders, Fook-Thean Lee, Violeta Spirkoska, Wendie Hopkins, Fiona E Smyth, Geoffrey Chong, Anthony T Papenfuss, Bridget Chappell, Aurora Poon, Timothy H Saunder, Eric W Hoffman, Lloyd J Old, Andrew M Scott

Journal article  |  2007  |  Cancer Immunity

The chimeric monoclonal antibody cG250 recognizes the CAIX/MN antigen. cG250 induces antibody-dependent cellular cytotoxicity (ADC..

Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma

Malcolm Ranson, Peter Hersey, Damien Thompson, Jane Beith, Grant A McArthur, Andrew Haydon, Ian D Davis, Richard F Kefford, Peter Mortimer, Peter A Harris, Sofia Baka, Augustus Seebaran, Ami Sabharwal, Amanda J Watson, Geoffrey P Margison, Mark R Middleton

Journal article  |  2007  |  Journal of Clinical Oncology

An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma

Ian D Davis, Birte K Skrumsager, Jonathan Cebon, Theo Nicholaou, John W Barlow, Niels Peter Hundahl Moller, Kresten Skak, Dorthe Lundsgaard, Klaus Stensgaard Frederiksen, Peter Thygesen, Grant A McArthur

Journal article  |  2007  |  Clinical Cancer Research

Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate

Theo Nicholaou, Rachel Wong, Ian D Davis

Journal article  |  2007  |  The Lancet

Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibody

SF Chew, BR Wood, C Kanaan, J Browning, D MacGregor, ID Davis, J Cebon, BD Tait, D McNaughton

Journal article  |  2007  |  Tissue Antigens

Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: Current practice

Nathan Lawrentschuk, Ian D Davis, Damien M Bolton, Andrew M Scott

Journal article  |  2007  |  International Journal of Urology

Renal cell cancer and positron emission tomography - an evolving diagnostic and therapeutic relationship

Nathan Lawrentschuk, Damien M Bolton, Ian D Davis, Andrew M Scott

Journal article  |  2007  |  Current Medical Imaging Reviews

Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy

Lee S Rosen, Ehtesham Abdi, Ian D Davis, John Gutheil, Frederick M Schnell, John Zalcberg, Alessandra Cesano, Urte Gayko, Mon-Gy Chen, Stephen Clarke

Journal article  |  2006  |  BJU International

Phase II study of vinflunine in patients with metastatic renal cell carcinoma

D Goldstein, SP Ackland, DR Bell, IN Olver, ID Davis, MA Rosenthal, GC Toner, MC Pinel, M Byrne

Journal article  |  2006  |  Investigational New Drugs

Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8( ) T cells efficiently in cancer patients

Ian D Davis, Qiyuan Chen, Leone Morris, Juliet Quirk, Maureen Stanley, Maria L Tavarnesi, Phillip Parente, Tina Cavicchiolo, Wendie Hopkins, Heather Jackson, Nektaria Dimopoulos, Tsin Yee Tai, Duncan MacGregor, Judy Browning, Suzanne Svobodova, Dania Caron, Eugene Maraskovsky, Lloyd J Old, Weisan Chen, Jonathan Cebon

Journal article  |  2006  |  Journal of Immunotherapy

A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors

HK Gan, PL Mitchell, P Galettis, ID Davis, J Cebon, P de Souza, M Links

Journal article  |  2006  |  Cancer Chemotherapy and Pharmacology

Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens

Elgene Lim, Judy Browning, Duncan MacGregor, Ian D Davis, Jonathan S Cebon

Journal article  |  2006  |  Melanoma Research

Striking immunodominance hierarchy of naturally occurring CD8( ) and CD4( ) T cell responses to tumor antigen NY-ESO-1

Heather Jackson, Nektaria Dimopoulos, Nicole A Mifsud, Tsin Yee Tai, Qiyuan Chen, Suzanne Svobodova, Judy Browning, Immanuel Luescher, Lisa Stockert, Lloyd J Old, Ian D Davis, Jonathan Cebon, Weisan Chen

Journal article  |  2006  |  Journal of Immunology

Positron emission tomography and molecular imaging of the prostate: an update

NATHAN LAWRENTSCHUK, IAN D DAVIS, DAMIEN M BOLTON, ANDREW M SCOTT

Journal article  |  2006  |  BJU International

Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship

Nathan Lawrentschuk, Ian D Davis, Damien M Bolton, Andrew M Scott

Journal article  |  2006  |  BJU International

Xenografting Tumour beneath the Renal Capsule Using Modern Surgical Equipment

Nathan Lawrentschuk, Angela Rigopoulos, Fook-Thean Lee, Ian D Davis, Andrew M Scott, Damien M Bolton

Journal article  |  2006  |  European Surgical Research

Directions in the immune targeting of cancer: Lessons learned from the cancer-testis Ag NY-ESO-1

undefined nicholaou, undefined ebert, I DAVIS, undefined robson, undefined klein, undefined maraskovsky, W CHEN, J CEBON

Journal article  |  2006  |  Immunology and Cell Biology

Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography

N Lawrentschuk, AMT Poon, SS Foo, LGJ Putra, C Murone, ID Davis, DM Bolton, AM Scott

Journal article  |  2005  |  BJU International

Impact of 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography on the management of patients with advanced melanoma

MT Harris, SU Berlangieri, JS Cebon, ID Davis, AM Scott

Journal article  |  2005  |  Molecular Imaging and Biology

Phase I trial of I-131-huA33 in patients with advanced colorectal carcinoma

G Chong, F Lee, W Hopkins, N Tebbutt, JS Cebon, AJ Mountain, B Chappel, A Papenfuss, P Schleyer, P U, R Murphy, V Wirth, FE Smyth, N Potasz, A Poon, ID Davis, T Saunder, GJ O'Keefe, AW Burgess, EW Hoffman, et al.

Journal article  |  2005  |  Clinical Cancer Research

Ventricular metastasis resulting in disseminated intravascular coagulation

T John, ID Davis

Journal article  |  2005  |  World Journal of Surgical Oncology

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery

M Schnurr, QY Chen, A Shin, WS Chen, T Toy, C Jenderek, S Green, L Miloradovic, D Drane, ID Davis, J Villadangos, K Shortman, E Maraskovsky, J Cebon

Journal article  |  2005  |  Blood

Characterization of antigen-specific CD8 T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination.

Qiyuan Chen, Heather Jackson, Mark Shackleton, Phillip Parente, Wendie Hopkins, Sue Sturrock, Duncan MacGregor, Eugene Maraskovsky, Tsin Yee Tai, Nektaria Dimopoulos, Kelly-Anne Masterman, Tina Luke, Ian D Davis, Weisan Chen, Jonathan Cebon

Journal article  |  2005  |  Cancer Immunity

Immune responses to cancer vaccines are commonly tested by measuring cutaneous reactions to intradermal (i.d.) antigen. When well-..

A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy

ID Davis

Journal article  |  2005  |  Clinical Cancer Research

Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.

Andrew M Scott, Zhanqi Liu, Carmel Murone, Terrance G Johns, Duncan MacGregor, Fiona E Smyth, Fook-Thean Lee, Jonathan Cebon, Ian D Davis, Wendie Hopkins, Angela J Mountain, Angela Rigopoulos, Nobuo Hanai, Lloyd J Old

Journal article  |  2005  |  Cancer Immunity

We conducted an open label dose-escalation phase I trial of chimeric anti-GD3 mAb KM871 in patients with metastatic melanoma. Pati..

Can't cope with 'acopoa' - letters to the editor

ID DAVIS, JD ZAJAC

Journal article  |  2005  |  Internal Medicine Journal

Recombinant NY-ESO-1 cancer antigen: Production and purification under cGMP conditions

R Murphy, S Green, G Ritter, L Cohen, D Ryan, W Woods, M Rubira, J Cebon, ID Davis, A Sjolander, A Kypridis, H Kalnins, M McNamara, MB Moloney, J Ackland, G Cartwright, J Rood, G Dumsday, K Healey, D Maher, et al.

Journal article  |  2005  |  Preparative Biochemistry & Biotechnology

Biochemotherapy for the treatment of metastatic melanoma: the experience of a tertiary oncology center

T JOHN, JS CEBON, ID DAVIS

Journal article  |  2005  |  Asia-Pacific Journal of Clinical Oncology

F-18-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy

LJ Putra, N Lawrentschuk, Z Ballok, A Hannah, A Poon, A Tauro, ID Davis, RJ Hicks, DM Bolton, AM Scott

Journal article  |  2004  |  Urology

The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.

Mark Shackleton, Ian D Davis, Wendie Hopkins, Heather Jackson, Nektaria Dimopoulos, Tsin Tai, Qiyuan Chen, Phillip Parente, Michael Jefford, Kelly-Anne Masterman, Dania Caron, Weisan Chen, Eugene Maraskovsky, Jonathan Cebon

Journal article  |  2004  |  Cancer Immunity

Dendritic cells (DCs) show promise as adjuvants in anticancer immunotherapeutic strategies. Flt3 ligand (FL) is a hematopoietic gr..

A robust human T-cell culture method suitable for monitoring CD8 and CD4 T-cell responses from cancer clinical trial samples

HM Jackson, N Dimopoulos, QY Chen, T Luke, TY Tai, E Maraskovsky, LJ Old, ID Davis, J Cebon, WS Chen

Journal article  |  2004  |  Journal of Immunological Methods

Metastatic basal cell carcinoma: Rapid symptomatic response to cisplatin and paclitaxel

M Jefford, JD Kiffer, G Somers, FJ Daniel, ID Davis

Journal article  |  2004  |  ANZ Journal of Surgery

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4 and CD8 T cell responses in humans

ID Davis, WS Chen, H Jackson, P Parente, M Shackleton, W Hopkins, QY Chen, N Dimopoulos, T Luke, R Murphy, AM Scott, E Maraskovsky, G McArthur, D MacGregor, S Sturrock, TY Tai, S Green, A Cuthbertson, D Maher, L Miloradovic, et al.

Journal article  |  2004  |  Proceedings of the National Academy of Sciences of the United States of America

Immunodominant CD4( ) responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

QY Chen, H Jackson, P Parente, T Luke, M Rizkalla, TY Tai, HC Zhu, NA Mifsud, N Dimopoulos, KA Masterman, W Hopkins, H Goldie, E Maraskovsky, S Green, L Miloradovic, J McCluskey, LJ Old, ID Davis, J Cebon, WS Chen

Journal article  |  2004  |  Proceedings of the National Academy of Sciences of the United States of America

A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer

M Jefford, M Michael, MA Rosenthal, ID Davis, M Green, B McClure, J Smith, B Waite, J Zalcberg

Journal article  |  2004  |  Investigational New Drugs

A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer

PLR Mitchell, R Basser, M Chipman, A Grigg, R Mansfield, J Cebon, ID Davis, F Appia, M Green

Journal article  |  2004  |  Annals of Oncology